These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5455839)

  • 21. Influenza A-equi-2 viruses isolated in Switzerland, 1965-1966. A comparative antigenic study.
    Paccaud MF; Paccaud M
    Pathol Microbiol (Basel); 1967; 30(6):999-1006. PubMed ID: 5627204
    [No Abstract]   [Full Text] [Related]  

  • 22. [Formation of specific influenza antibodies in sheep].
    Glathe H
    Z Gesamte Hyg; 1967 Jul; 13(7):519-22. PubMed ID: 5594129
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model.
    Lipatov AS; Webby RJ; Govorkova EA; Krauss S; Webster RG
    J Infect Dis; 2005 Apr; 191(8):1216-20. PubMed ID: 15776365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of interferon on the dynamics of antibody formation in chickens in avian pseudopest].
    Litvinov AN
    Antibiotiki; 1967 Jul; 12(7):602-4. PubMed ID: 4299327
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental demonstration of the capacity of the influenza virus persisting in the body to cause a slow infection].
    Zuev VA; Mirchink EP; Kharitonova AM
    Vestn Akad Med Nauk SSSR; 1985; (3):26-31. PubMed ID: 3993190
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study of experimental streptococcal, influenzal and mixed infections].
    Loziuk LV; Volos OP
    Mikrobiol Zh; 1977; 39(4):458-61. PubMed ID: 333242
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of a mixed influenza-RS-virus infection in experiments on white mice].
    Ritova VV; Larionov AS; Moiseev VP; Pshenichnikov VV
    Biull Eksp Biol Med; 1971 Dec; 72(12):31-3. PubMed ID: 5132134
    [No Abstract]   [Full Text] [Related]  

  • 28. Virus multiplication and interferon formation in lungs from mice infected with A2 influenza virus.
    Link F; Blaskovic D; Raus J
    Acta Virol; 1965 Jul; 9(4):380. PubMed ID: 4379495
    [No Abstract]   [Full Text] [Related]  

  • 29. Influenza A2 inhibits murine in vitro antibody synthesis.
    Daniels CA; Marbrook J
    J Immunol; 1981 May; 126(5):1737-41. PubMed ID: 6971313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of immunosuppression on the genetic resistance of A2G mice to neurovirulent influenza virus.
    Fiske RA; Klein PA
    Infect Immun; 1975 Mar; 11(3):576-87. PubMed ID: 163800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Original antigenic sin in ferrets: the response to sequential infections with influenza viruses.
    Webster RG
    J Immunol; 1966 Aug; 97(2):177-83. PubMed ID: 5921310
    [No Abstract]   [Full Text] [Related]  

  • 32. Influenza virus growth and antibody response in amantadine-treated mice.
    Davies WL; Grunert RR; Hoffmann CE
    J Immunol; 1965 Dec; 95(6):1090-4. PubMed ID: 5850540
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
    Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral and cell-mediated immune response to influenza virus. I. Experiments in mice.
    Semkow R; Loza-Tulimowska M; Wilczyński J; Brydak L; Zgorzelska K
    Acta Microbiol Pol; 1982; 31(2):185-94. PubMed ID: 6188341
    [No Abstract]   [Full Text] [Related]  

  • 35. Communications. Antigenic relationship between the equine and the Hong Kong human variant of influenza type A2 virus.
    Kasel JA; Fulk RV; Couch RB
    J Immunol; 1969 Feb; 102(2):530-2. PubMed ID: 5812724
    [No Abstract]   [Full Text] [Related]  

  • 36. A serologic study of equine influenza.
    Halterman LG; McQueen JL
    J Am Vet Med Assoc; 1968 Oct; 153(8):1069-73. PubMed ID: 5693156
    [No Abstract]   [Full Text] [Related]  

  • 37. [Persistent infection in mice caused by the administration of a "defective" population of the influenza virus].
    Shcherbinskaia AM
    Mikrobiol Zh (1978); 1983; 45(5):71-5. PubMed ID: 6400783
    [No Abstract]   [Full Text] [Related]  

  • 38. A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza.
    Vajdy M; Baudner B; Del Giudice G; O'Hagan D
    Clin Immunol; 2007 May; 123(2):166-75. PubMed ID: 17349825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Viral characteristics and immunologic reactions of the body during adaptation of influenza virus type A to mice. III. Biological properties of viruses used for adaptation and mouse-adapted viruses].
    Loza-Tulimowska M
    Med Dosw Mikrobiol; 1984; 36(1):55-61. PubMed ID: 6330475
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on pathogenicity and immunogenicity of cold adapted variants of influenza virus.
    Brydak L
    Acta Microbiol Pol; 1982; 31(3-4):287-92. PubMed ID: 6189378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.